198 related articles for article (PubMed ID: 6306051)
1. Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets.
Insogna KL; Broadus AE; Gertner JM
J Clin Invest; 1983 Jun; 71(6):1562-9. PubMed ID: 6306051
[TBL] [Abstract][Full Text] [Related]
2. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
5. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
Short E; Morris RC; Sebastian A; Spencer M
J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcitriol on serum 1,25 (OH) 2D3 levels and on renal phosphorous threshold in X-linked hypophosphatemic rickets.
Mehls O; Manz F; Kettenmann K; Bonjour JP; Trechsel U
Adv Exp Med Biol; 1984; 178():411-3. PubMed ID: 6548864
[No Abstract] [Full Text] [Related]
7. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
Lyles KW; Halsey DL; Friedman NE; Lobaugh B
J Clin Endocrinol Metab; 1988 Jul; 67(1):88-92. PubMed ID: 3379139
[TBL] [Abstract][Full Text] [Related]
8. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
10. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
[TBL] [Abstract][Full Text] [Related]
11. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.
Hahn TJ; Scharp CR; Halstead LR; Haddad JG; Karl DM; Avioli LV
J Clin Endocrinol Metab; 1975 Nov; 41(5):926-37. PubMed ID: 1184724
[TBL] [Abstract][Full Text] [Related]
13. Serum parathyroid hormone in X-linked hypophosphatemia.
Arnaud C; Glorieux F; Scriver C
Science; 1971 Aug; 173(3999):845-7. PubMed ID: 5315247
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
Meyer RA; Gray RW; Roos BA; Kiebzak GM
Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
Yasuda T; Nakajima H
Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
[TBL] [Abstract][Full Text] [Related]
19. Permissive action of growth hormone on the renal response to dietary phosphorus deprivation.
Harbison MD; Gertner JM
J Clin Endocrinol Metab; 1990 Apr; 70(4):1035-40. PubMed ID: 2180972
[TBL] [Abstract][Full Text] [Related]
20. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
